Efficacy and Safety of Eplerenone, Enalapril, and Eplerenone/Enalapril Combination Therapy in Patients With Left Ventricular Hypertrophy - 4E


The goal of the trial was to assess the relative efficacy of treatment with either eplerenone, an aldosterone antagonist, or the angiotensin-converting enzyme inhibitor enalapril in patients with mild-to-moderate hypertension and left ventricular hypertrophy (LVH).